View Clinical Trial (Medical Research Study)
Phase II Study of HMPL-004 in Subjects With Crohn's Disease - NCT00655733-19406(Clinical Trial 213403)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
King of Prussia |
|
State:
|
|
PA |
| Zip Code: |
|
19406 |
| Conditions: |
|
Crohn's Disease |
| Purpose: |
|
Double-blind, randomized, multicenter, placebo-controlled study The purpose of this study is
to evaluate the efficacy and safety of HMPL-004 in patients with active moderate Crohn's
Disease,compared with placebo.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Have active confirmed Crohn's Disease (confirmed radiographically, endoscopic, or
histologically), with a CDAI of 220-400 at baseline screen
Exclusion Criteria:
- They have received anti-TNF-α antibody within 3 months of starting study medication,
or cyclosporine, tacrolimus, thalidomide or mycophenolate mofetil within 2 months of
starting study medication |
|
|
|
| Study is available at: |
|
Omnicare Clinical Research, Inc.
King of Prussia, PA 19406
United States
Primary Contact:
Xiaowei Lu, MD
Email: Xiaowei.Lu@OmnicareCR.com
Phone: 973-325-5668
Secondary Contact:
Xiaowei Lu, MD
Email: Xiaowei.Lu@OmnicareCR.com
Phone: 973-325-5668 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|